Nuclear Medicine and Biology
Volume 33, Issue 5 , Pages 635-643 , July 2006

99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death

  • Archana Mukherjee

      Affiliations

    • Radiopharmaceuticals Division, Radiochemistry and Isotope Group, Bhabha Atomic Research Centre, Mumbai-400085, India
    • ,
  • Kanchan Kothari

      Affiliations

    • Radiopharmaceuticals Division, Radiochemistry and Isotope Group, Bhabha Atomic Research Centre, Mumbai-400085, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 22 2559 5371; fax: +91 22 2550 5345, +91 22 2551 9613.
    • ,
  • Géza Tóth

      Affiliations

    • Biological Research Centre of the Hungarian Academy of Sciences, H-6701 Szeged, Hungary
    • ,
  • Erzsébet Szemenyei

      Affiliations

    • Biological Research Centre of the Hungarian Academy of Sciences, H-6701 Szeged, Hungary
    • ,
  • Hal Dhar Sarma

      Affiliations

    • Radiation Biology and Health Science Division, Bhabha Atomic Research Centre, Mumbai-400085, India
    • ,
  • József Környei

      Affiliations

    • Institute of Isotopes Co. Ltd., H1121, Budapest, Hungary
    • ,
  • Meera Venkatesh

      Affiliations

    • Radiopharmaceuticals Division, Radiochemistry and Isotope Group, Bhabha Atomic Research Centre, Mumbai-400085, India

Received 10 November 2005 ,Revised 27 February 2006 ,Accepted 16 May 2006.

References 

  1. Boris Z, Bertrand J, Orrenius S. Tumor radiosensitivity and apoptosis. Expt Cell Res. 1999;248:10–17
  2. Kabelitz D. Apoptosis, graft rejection and transplantation tolerance. Transplantation. 1998;65:869–875
  3. Mattson MP, Culmsee C, Yu ZF. Apoptosis and antiapoptotic mechanisms in stroke. Cell Tissue Res. 2000;301:173–187
  4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456–1462
  5. Zucker RM, Hunter ES, Rogers JM. Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods. 1999;18:473–480
  6. Hakumaki JM, Poptani H, Sandmair AM, Yia-Herttuala S, Kauppinen RA. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med. 1999;5:1323–1327
  7. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148:2207–2216
  8. Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K. Human placental anticoagulant protein: isolation and characterization. Biochemistry. 1987;26:5572–5578
  9. Reutelingsperger CPM, Hornstra G, Hemker HC. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem. 1985;151:625–629
  10. Maurer-Fogy I, Reutelingsperger CPM, Pieters J, Bodo G, Stratowa C, Hauptmann R. Cloning and expression of cDNA for human vascular anticoagulant, a Ca2+-dependent phospholipid-binding protein. Eur J Biochem. 1988;174:585–592
  11. Subbarayan M, Hafeli UO, Feyes DK, Unnithan J, Emancipator SN, Mukhtar H. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med. 2003;44:650–656
  12. Steinmetz ND, Green Am. Chemotherapy induced change in 99mTc HYNIC-annexin V uptake as an early predictor of response to platinum therapy in advanced non-small cell lung cancer. J Nucl Med. 2004;45:36P
  13. Post AM, Katsikis PD, Tait JF, Geaghan SM, Strauss HW, Blankenberg FG. Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. J Nucl Med. 2002;43:1359–1365
  14. Blankenberg FG, Naumovski L, Tait JF, Post AM, Strauss HW. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc radiolabeled annexin V. J Nucl Med. 2001;42:309–316
  15. Zijlstra S, Gunawan J, Burchert W. Synthesis and evaluation of a 18F labeled recombinant annexin-V derivative for identification and quantification of apoptotic cells with PET. Appl Radiat Isot. 2003;58:201–207
  16. Toretsky J, Levenson A, Weinberg IN, Tait JF, Uren A, Mease RC. Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death. Nucl Med Biol. 2004;31:747–752
  17. McQuade P, Jones LA, Vanderheyden JL, Welch MJ. 94mTc and 64Cu labeled annexin V positron-emitting radiopharmaceuticals. J Label Compd Radiopharm. 2003;46:S1–S4
  18. Dekker B, Keen H, Shaw D, Disley L, Hastings D, Hadfield J, et al. Functional comparison of annexin V analogues labeled indirectly and directly with iodine 124. Nucl Med Biol. 2005;32:403–413
  19. Glaser M, Collingridge DR, Aboagye EO, Hayes LB, Hutchinson OC, Martin SJ, et al. Iodine-124 labeled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography. Appl Radiat Isot. 2003;58:55–62
  20. Lahorte C, Slegers G, Philippe J, van de Wiele C, Dierckx RA. Synthesis and in vitro evaluation of 123I-labeled human recombinant annexin V. Biomol Eng. 2001;17:51–53
  21. Russell J, O'Donoghue JA, Finn R, Koziorowski J, Ruan S, Humm JL, et al. Iodination of annexin V for imaging apoptosis. J Nucl Med. 2002;43:671–677
  22. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. In vivo detection and imaging of phophatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 1998;95:6349–6354
  23. Hoftstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, et al. Visualization of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;356:209–212
  24. Keen HG, Dekker BA, Disley L, Hastings D, Lyons S, Reader AJ, et al. Imaging apoptosis in vivo using 124I annexin V and PET. Nucl Med Biol. 2005;32:395–402
  25. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J. Nucl Med. 1999;40:184–191
  26. Boersma HH, Bennaghmouch A, Heidenal GAK, Kietselaer BLJH, Hofstra L, Stolk LML, et al. Past present and future of annexin A5: from protein discovery to clinical application. J Nucl Med. 2005;46:2035–2050
  27. Mearly T, Meers P. Calcium dependent annexin binding to phospholipids: stoichiometry, specificity and role of negative charge. Biochemistry. 1993;32:11711–11721
  28. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for gene family multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta. 1994;1197:63–93
  29. Hayashi H, Owada MK, Sonobe S, Kakunaga T. Characterization of two distinct Ca2+ dependent phospholipid binding proteins of 68 kDa isolation from placenta. J Biol Chem. 1989;264:17222–17230
  30. Pepinsky RB, Sinclair LK, Chow EP, Obrinegreco B. A dimeric form of lipocortin-1 in human placenta. Biochem J. 1989;263:97–103
  31. Signore A, Annovazzi A, Chianelli M, Corsetti F, Van de Wiele C, Watherhouse RN. Scopinaro, peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med. 2001;28:1555–1565
  32. Kornyei J, Toth G, Szemenyei E, Duatti A. Development of annexin V fragments for labeling with 99mTc. Report 2nd research coordination meeting on “Development of 99mTc based small biomolecules using novel 99mTc cores”. Vienna: IAEA; 2004;
  33. Kothari K, Pillai MRA. In: International symposium on radiochemistry and radiation chemistry, AR-19, 1-2, Bhabha Atomic Research Center, Bombay, India. 2000;
  34. Stewart JM, Young JD. Solid phase peptide synthesis. 2nd ed. Rockford (IL): Pierce Chemical Company; 1984;
  35. Tömböly C, Kövér K, Péter A, Tourwé D, Biyeshev D, Benyhe S, et al. Structure–activity on the Phe side chain arrangement of endomorphins using conformationally constrained analogues. J Med Chem. 2004;447:735–743
  36. Gisin BF. The preparation of Merrifield-resins through total esterification with cesium salts. Helv Chim Acta. 1973;56:1476–1482
  37. Alberto R, Schibli R, Egli A, Schubiger AP, Abram U, Kaden TA. A novel organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of [Tc-99m (OH2)3(CO)3]+ from [(TcO4)-Tc-99m] in aqueous solution and its reaction with a bifunctional ligand. J Am Chem Soc. 1998;120:7987–7988
  38. Boersma HH, Stolk LM, Kenis H, Deckers NN, Vanderheyden JL, Guido LH, et al. The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent annexin A5. Anal Biochem. 2004;327:126–134
  39. Kemerink GJ, Liu X, Kieffer D, Kieffer D, Ceyssens S, Mortelmans L, et al. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med. 2003;44:947–952
  40. Glasier M, Collingridge DR, Aboagye EO, Hayes LB, Hutchinson OC, Martin SJ, et al. Iodine-124 labelled annexin V as a potential radiotracer to study apoptosis using positron emission tomography. Appl Radiat Isot. 2003;58:55–62
  41. Boschi A, Bolzati C, Benini E, Malago E, Uccelli L, Duatti A, et al. A novel approach to the high specific activity labeling of small peptides with the technetium-99m fragment [99mTc(N)(PXP)]2+ (PXP=diphosphine ligand). Bioconjug Chem. 2001;12:1035–1042
  42. Hom R, Katzenellenbogen J. Technetium-99m labeled receptor-specific small molecule radiopharmaceuticals: recent developments and encouraging results. Nucl Med Biol. 1997;24:485–498
  43. Dilworth JR, Parrot S. The biomedical chemistry of technetium and rhenium. Chem Soc Rev. 1998;27(Suppl):43–55
  44. Tait JF, Smith C, Gibson DF. Development of annexin V mutants suitable for labeling with Tc (i)-carbonyl complex. Bioconjug Chem. 2002;13:1119–1123
  45. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456–1462
  46. Blankenberg FG, Strauss HW. Nuclear medicine applications in molecular imaging. J Magn Reson Imaging. 2002;16:352–361

PII: S0969-8051(06)00094-1

doi: 10.1016/j.nucmedbio.2006.05.002

Nuclear Medicine and Biology
Volume 33, Issue 5 , Pages 635-643 , July 2006

Article Tools

* Image Usage & Resolution